Dr. Reddy's Laboratories Limited Operating Cycle 2011-2026 | RDY

Annual Operating Cycle Dr. Reddy's Laboratories Limited

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	279	-	-	167	150	148	155	-	-	170

All numbers in INR currency

Maximum	Minimum	Average
279	148	178

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Aptorum Group Limited APM	4.89	$ 0.81	1.31 %	$ 4.42 M	China
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Axsome Therapeutics AXSM	273	$ 167.61	-4.09 %	$ 8.34 B	USA
Albireo Pharma ALBO	40.8	-	-0.23 %	$ 916 M	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
Acorda Therapeutics ACOR	394	-	-24.86 %	$ 820 K	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
BioMarin Pharmaceutical BMRN	819	$ 63.02	0.15 %	$ 12 B	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
CASI Pharmaceuticals CASI	135	$ 0.79	4.29 %	$ 108 M	USA
Catalyst Biosciences CBIO	410	$ 12.71	10.81 %	$ 837 M	USA
Aeterna Zentaris AEZS	115	-	5.93 %	$ 314 M	Canada
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Aridis Pharmaceuticals ARDS	59	-	17.91 %	$ 11.1 M	USA
Amneal Pharmaceuticals AMRX	123	$ 14.72	2.08 %	$ 4.55 B	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Certara CERT	88.6	$ 6.67	2.77 %	$ 1.07 B	USA